Bubble Super Clear Blemish Prevention Serum

Description

The product is identified by the SPL code 34089-3. No additional specific details regarding its chemical composition, dosage form, or physical characteristics are available in the provided information.

Uses and Indications

This drug is indicated for the treatment of acne. It is also intended to help prevent the formation of new blemishes.

Dosage and Administration

Prior to the initial application, a patch test should be conducted to assess for any potential allergic reactions. The skin must be cleaned thoroughly to ensure optimal adherence and effectiveness of the product.

The recommended application involves covering the entire affected area with a thin layer. Initially, the product should be applied once daily. Based on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the frequency of application to once daily or every other day to mitigate these side effects.

Contraindications

There are no specific contraindications identified for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. This product should be applied exclusively to the skin and not ingested. It is imperative to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Healthcare professionals should be aware that skin irritation or dryness may occur, particularly when this product is used concurrently with other topical acne medications. In cases of irritation, it is advised to limit the use of acne treatments to one at a time and to reduce the frequency of application to every other day to mitigate adverse effects. Monitoring for signs of skin irritation is essential to ensure patient safety and comfort.

Side Effects

For external use only. Patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, medical help should be sought immediately, or contact a Poison Control Center.

When using this product, participants may experience skin irritation or dryness, particularly if it is used concurrently with other topical acne medications. In such cases, it is recommended that patients utilize only one acne treatment at a time and consider reducing the frequency of application to every other day to mitigate these adverse reactions.

Drug Interactions

Skin irritation or dryness may occur when this medication is used concurrently with other topical acne treatments. To mitigate these effects, it is advised to limit the use of acne treatments to one at a time. In cases where irritation or dryness develops, it is recommended to reduce the frequency of application to every other day. Monitoring for skin reactions is essential to ensure patient comfort and treatment adherence.

Packaging & NDC

Below are the non-prescription pack sizes of Bubble Super Clear Blemish Prevention Serum (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this product. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Prior to application, a patch test should be conducted to assess for any adverse reactions. Due to the potential for excessive drying of the skin, it is recommended to initiate treatment with one application daily. If tolerated, the frequency may be gradually increased to two or three times daily, as directed by a healthcare professional. Should bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been evaluated for use during pregnancy. Currently, there are no specific warnings or contraindications associated with the use of this product in pregnant patients. Additionally, the prescribing information does not provide any dosage modifications for individuals who are pregnant. There are also no special precautions regarding the use of this product during pregnancy. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control and emergency medical services is recommended to ensure optimal management and patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Serious adverse effects have been reported in the postmarketing experience. In such cases, healthcare professionals and patients are advised to contact the designated reporting line at +1 (651) 504-2243 for further assistance and guidance.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion.

Additionally, healthcare providers should inform patients that skin irritation or dryness may occur, particularly when the medication is used in conjunction with other topical acne treatments. In such cases, patients should be counseled to use only one acne treatment at a time and to consider reducing the frequency of application to every other day to minimize adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the recommended temperature range to maintain its integrity and efficacy. Storage should be avoided at extreme temperatures, specifically below 40°F and above 100°F. Proper container requirements must be adhered to, ensuring that the product is kept in a suitable environment to prevent degradation. Special handling needs should be observed to ensure the product remains within the specified conditions throughout its storage and handling processes.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Bubble Super Clear Blemish Prevention Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)